Remission of food allergy by the Janus kinase inhibitor ruxolitinib in mice

International Immunopharmacology

Volumn 18, Issue 2, 2014, Pages 217-224

  Yamaki, Kouya ^a   Yoshino, Shin ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Anaphylaxis; Food allergy; Janus kinase; Mast cells; Ruxolitinib

Indexed keywords

BRINASE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 9; OVALBUMIN; RUXOLITINIB;

ANAPHYLAXIS; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL HYPERPLASIA; CONTROLLED STUDY; DEGRANULATION; ENZYME SYNTHESIS; FOOD ALLERGY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REMISSION; SPLEEN CELL;

ANAPHYLAXIS; BMMCS; BONE MARROW-DERIVED MAST CELLS; FA; FOOD ALLERGY; JAK; JANUS KINASE; MAST CELLS; MCS; MMCP; MOUSE MAST CELL PROTEASE; OVA; OVALBUMIN; PASSIVE SYSTEMIC ANAPHYLAXIS; PSA; REGULATORY T CELL TYPE; RUXOLITINIB; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; STAT; TR;

ALLERGENS; ANIMALS; BONE MARROW CELLS; CELL LINE; CHYMASES; CYTOKINES; FOOD HYPERSENSITIVITY; GOBLET CELLS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTESTINES; JANUS KINASES; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; PROTEIN KINASE INHIBITORS; PYRAZOLES; SPLEEN;

EID: 84891688354     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.11.029     Document Type: Article

References (43)

1. S.R. Boden, and Burks A. Wesley Anaphylaxis: a history with emphasis on food allergy Immunol Rev 242 2011 247 257
2. A.W. Burks, M. Tang, S. Sicherer, A. Muraro, P.A. Eigenmann, and M. Ebisawa et al. ICON: food allergy J Allergy Clin Immunol 129 2012 906 920
3. S. Prescott, and K.J. Allen Food allergy: riding the second wave of the allergy epidemic Pediatr Allergy Immunol 22 2011 155 160
4. R.S. Gupta, E.E. Springston, M.R. Warrier, B. Smith, R. Kumar, and J. Pongracic et al. The prevalence, severity, and distribution of childhood food allergy in the United States Pediatrics 128 2011 e9 e17
5. S.C. Bischoff Food allergies Curr Gastroenterol Rep 8 2006 374 382 (Pubitemid 44515359)
6. C.A. Keet, and R.A. Wood Food allergy and anaphylaxis Immunol Allergy Clin North Am 27 2007 193 212 [vi.] (Pubitemid 46686986)
7. E.B. Brandt, R.T. Strait, D. Hershko, Q. Wang, E.E. Muntel, and T.A. Scribner et al. Mast cells are required for experimental oral allergen-induced diarrhea J Clin Invest 112 2003 1666 1677 (Pubitemid 38063724)
8. L.C. Yu, and M.H. Perdue Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress Immunol Rev 179 2001 61 73 (Pubitemid 32171274)
9. X.P. Lin, J. Magnusson, S. Ahlstedt, A. Dahlman-Hoglund, L.L. Hanson, and O. Magnusson et al. Local allergic reaction in food-hypersensitive adults despite a lack of systemic food-specific IgE J Allergy Clin Immunol 109 2002 879 887 (Pubitemid 34499525)
10. L.B. Schwartz, D.D. Metcalfe, J.S. Miller, H. Earl, and T. Sullivan Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis N Engl J Med 316 1987 1622 1626 (Pubitemid 17082588)
11. J.K. Morales, Y.T. Falanga, A. Depcrynski, J. Fernando, and J.J. Ryan Mast cell homeostasis and the JAK-STAT pathway Genes Immun 11 2010 599 608
12. A. Quintas-Cardama, K. Vaddi, P. Liu, T. Manshouri, J. Li, and P.A. Scherle et al. Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms Blood 115 2010 3109 3117
13. P.S. Changelian, M.E. Flanagan, D.J. Ball, C.R. Kent, K.S. Magnuson, and W.H. Martin et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor Science 302 2003 875 878 (Pubitemid 37339629)
14. J. Mascarenhas, and R. Hoffman Ruxolitinib: the first FDA approved therapy for the treatment of myelofibrosis Clin Cancer Res 18 2012 3008 3014
15. G.R. Burmester, R. Blanco, C. Charles-Schoeman, J. Wollenhaupt, C. Zerbini, and B. Benda et al. Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial Lancet 381 2013 451 460
16. K. Yamaki, and S. Yoshino Preventive and therapeutic effects of rapamycin, a mammalian target of rapamycin inhibitor, on food allergy in mice Allergy 67 2012 1259 1270
17. K. Yamaki, and S. Yoshino Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice Allergy 67 2012 114 122
18. K. Yamaki, and S. Yoshino Comparison of inhibitory activities of zinc oxide ultrafine and fine particulates on IgE-induced mast cell activation Biometals 22 2009 1031 1040
19. K. Yamaki, X. Li, H. Uchida, A.H. Alam, M.A. Hossain, and R. Yanagisawa et al. Effects of the phosphodiesterase IV inhibitor rolipram on Th1 and Th2 immune responses in mice J Pharm Pharmacol 56 2004 877 882 (Pubitemid 38885981)
20. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 55 63 (Pubitemid 14203433)
21. E.E. Forbes, K. Groschwitz, J.P. Abonia, E.B. Brandt, E. Cohen, and C. Blanchard et al. IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity J Exp Med 205 2008 897 913 (Pubitemid 351549886)
22. Food and Drug Administration FDA ruxolitinib. Center for Drug Evaluation and Research, 202192Orig1s000 Pharmacol Rev 2011 98 [URL: http://www.accessdata. fda.gov/drugsatfda-docs/nda/2011/202192orig1s000pharmr.pdf.]
23. O. Silvennoinen, B.A. Witthuhn, F.W. Quelle, J.L. Cleveland, T. Yi, and J.N. Ihle Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction Proc Natl Acad Sci U S A 90 1993 8429 8433 (Pubitemid 23277682)
24. M.F. Brizzi, M.G. Zini, M.G. Aronica, J.M. Blechman, Y. Yarden, and L. Pegoraro Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase J Biol Chem 269 1994 31680 31684
25. T.R. Hundley, A.M. Gilfillan, C. Tkaczyk, M.V. Andrade, D.D. Metcalfe, and M.A. Beaven Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells Blood 104 2004 2410 2417 (Pubitemid 39331841)
26. S. Zhang, S. Fukuda, Y. Lee, G. Hangoc, S. Cooper, and R. Spolski et al. Essential role of signal transducer and activator of transcription (Stat)5a but not Stat5b for Flt3-dependent signaling J Exp Med 192 2000 719 728
27. C.P. Shelburne, M.E. McCoy, R. Piekorz, V. Sexl, K.H. Roh, and S.M. Jacobs-Helber et al. Stat5 expression is critical for mast cell development and survival Blood 102 2003 1290 1297 (Pubitemid 36988035)
28. O. Malbec, K. Roget, C. Schiffer, B. Iannascoli, A.R. Dumas, and M. Arock et al. Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells J Immunol 178 2007 6465 6475 (Pubitemid 46717430)
29. R. Ishikawa, Y. Tsujimura, K. Obata, Y. Kawano, Y. Minegishi, and H. Karasuyama IgG-mediated systemic anaphylaxis to protein antigen can be induced even under conditions of limited amounts of antibody and antigen Biochem Biophys Res Commun 402 2010 742 746
30. S.C. Bischoff, G. Sellge, A. Lorentz, W. Sebald, R. Raab, and M.P. Manns IL-4 enhances proliferation and mediator release in mature human mast cells Proc Natl Acad Sci U S A 96 1999 8080 8085 (Pubitemid 29328411)
31. R.T. Strait, A. Mahler, S. Hogan, M. Khodoun, A. Shibuya, and F.D. Finkelman Ingested allergens must be absorbed systemically to induce systemic anaphylaxis J Allergy Clin Immunol 127 2011 982 989 [e1]
32. E. Maier, A. Duschl, and J. Horejs-Hoeck STAT6-dependent and -independent mechanisms in Th2 polarization Eur J Immunol 42 2012 2827 2833
33. D.A. Lebman, and R.L. Coffman Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures J Exp Med 168 1988 853 862
34. O.T. Burton, A.R. Darling, J.S. Zhou, M. Noval-Rivas, T.G. Jones, and M.F. Gurish et al. Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy Mucosal Immunol 6 2012 740 750
35. L. Hultner, C. Druez, J. Moeller, C. Uyttenhove, E. Schmitt, and E. Rude et al. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9) Eur J Immunol 20 1990 1413 1416 (Pubitemid 20206111)
36. J.R. Reader, J.S. Tepper, E.S. Schelegle, M.C. Aldrich, L.F. Putney, and J.W. Pfeiffer et al. Pathogenesis of mucous cell metaplasia in a murine asthma model Am J Pathol 162 2003 2069 2078 (Pubitemid 36613062)
37. L. Cohn, L. Whittaker, N. Niu, and R.J. Homer Cytokine regulation of mucus production in a model of allergic asthma Novartis Found Symp 248 2002 201 213 [discussion 13-20, 77-82]
38. J. Turner, and C.E. Jones Regulation of mucin expression in respiratory diseases Biochem Soc Trans 37 2009 877 881
39. M. Severgnini, S. Takahashi, L.M. Rozo, R.J. Homer, C. Kuhn, and J.W. Jhung et al. Activation of the STAT pathway in acute lung injury Am J Physiol Lung Cell Mol Physiol 286 2004 L1282 L1292
40. U. Bengtsson, L.A. Hanson, and S. Ahlstedt Survey of gastrointestinal reactions to foods in adults in relation to atopy, presence of mucus in the stools, swelling of joints and arthralgia in patients with gastrointestinal reactions to foods Clin Exp Allergy 26 1996 1387 1394 (Pubitemid 27019794)
41. M. Wang, K. Takeda, Y. Shiraishi, M. Okamoto, A. Dakhama, and A. Joetham et al. Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcεRI-IL-13 pathway J Allergy Clin Immunol 126 2010 306 316 [16 e1-12]
42. H.F. Costa, F.C. Leite, A.F. Alves, J.M. Barbosa-Filho, C.R. dos Santos, and M.R. Piuvezam Managing murine food allergy with Cissampelos sympodialis Eichl (Menispermaceae) and its alkaloids Int Immunopharmacol 17 2013 300 308
43. J.S. Fridman, P.A. Scherle, R. Collins, T.C. Burn, Y. Li, and J. Li et al. Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050 J Immunol 184 2010 5298 5307